Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Chemed ( (CHE) ) has shared an update.
On June 27, 2025, Chemed Corporation announced that it expects lower earnings for the second quarter and has reduced its full-year guidance for 2025. This announcement may impact the company’s operations and industry positioning, potentially affecting stakeholders’ expectations and market confidence.
The most recent analyst rating on (CHE) stock is a Buy with a $708.00 price target. To see the full list of analyst forecasts on Chemed stock, see the CHE Stock Forecast page.
Spark’s Take on CHE Stock
According to Spark, TipRanks’ AI Analyst, CHE is a Outperform.
Chemed demonstrates robust financial performance and growth potential, particularly in the VITAS segment, which is offset by challenges in the Roto Rooter division. The technical analysis and valuation suggest a balanced view of its current stock price. Earnings call insights further support optimism in growth prospects despite some operational challenges.
To see Spark’s full report on CHE stock, click here.
More about Chemed
Average Trading Volume: 133,372
Technical Sentiment Signal: Hold
Current Market Cap: $8.08B
For an in-depth examination of CHE stock, go to TipRanks’ Overview page.